Oppenheimer & Co’s NEVRO CORP. NVRO Stock Holding History

Oppenheimer & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,504	Closed	-$210K	–	1575
2021 Q1	$210K	Hold	1,504	–	–	﹤0.01%	1333
2020 Q4	$260K	Hold	1,504	–	–	0.01%	1141
2020 Q3	$210K	Buy	+1,504	New	+$201K	0.01%	1136
2017 Q4	–	Sell	-2,220	Closed	-$202K	–	1370
2017 Q3	$202K	Sell	2,220 -14,403	-87%	-$1.23M	0.01%	1184
2017 Q2	$1.24M	Buy	+16,623	New	+$1.33M	0.03%	525
2017 Q1	–	Sell	-16,155	Closed	-$1.17M	–	1360
2016 Q4	$1.17M	Buy	+16,155	New	+$1.38M	0.03%	512
2016 Q2	–	Sell	-19,642	Closed	-$1.1M	–	1307
2016 Q1	$1.1M	Buy	+19,642	New	+$1.16M	0.03%	512
2015 Q4	–	Sell	-22,402	Closed	-$1.04M	–	1376
2015 Q3	$1.04M	Buy	22,402 +7,538	+51%	+$365K	0.03%	567
2015 Q2	$799K	Buy	14,864 +5,522	+59%	+$281K	0.02%	701
2015 Q1	$447K	Sell	9,342 -7,606	-45%	-$330K	0.01%	915
2014 Q4	$656K	Buy	+16,948	New	+$534K	0.02%	735

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Oppenheimer & Co's NVRO Position: Q2 2021 in Review

Oppenheimer & Co sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 1,504 shares — an estimated $210K sold.

Oppenheimer & Co first reported a position in NVRO in Q4 2014 and held it in 11 quarters. The position peaked at $1.24M in Q2 2017. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

Oppenheimer & Co reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
Oppenheimer & Co sold 1,504 NEVRO CORP. shares in Q2 2021, an estimated $210K.
Oppenheimer & Co first reported a position in NEVRO CORP. in Q4 2014 and held it in 11 quarters.
Oppenheimer & Co's NEVRO CORP. position peaked at $1.24M in Q2 2017.
207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.